Lawyers seeking to block the Trump administration’s decision to alter rules for the Title X family planning program say their efforts will not be stymied by the Supreme Court’s approval of similar rules 28 years ago. They point to new protections enacted in the Affordable Care Act and language in funding bills that shifts the legal calculus.
The new regulation would drop previous rules for the Title X program requiring that women with unintended pregnancies be told about all options, including abortion. It would also mandate that organizations separate facilities providing federally funded services and those providing abortions.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
Federal family planning funds, known as Title X, will soon fund for-profit women’s clinics that bar condoms, hormonal birth control and IUDs and offer only “natural family planning.”
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico talk about the latest court challenge to the Affordable Care Act, nomination hearings for Supreme Court nominee Brett Kavanaugh and news from the reproductive health front. Plus, Rovner interviews Chad Terhune about the latest KHN/NPR “Bill of the Month” installment.
